Locations:
Search IconSearch
November 18, 2025/Neurosciences/Cerebrovascular

MIS Evacuation Improves Survival in Moderate-Size Putaminal Hemorrhage

Anatomical modeling can identify optimal surgical candidates, study suggests

brain scan showing hemorrhage in the putamen

A Cleveland Clinic study focused exclusively on moderate-size putaminal intracranial hemorrhages (pICHs) has challenged previous notions about the efficacy of minimally invasive surgical (MIS) evacuation in this difficult-to-treat patient population. The findings, published in the Journal of Neurosurgery, suggest that MIS evacuation of pICHs from 10 to 50 mL in volume is associated with significantly lower one-year mortality and a shorter ICU length of stay (LOS) compared with maximal medical management.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Putaminal ICH is a subtype of basal ganglia ICH (bgICH). While prior large-scale trials have shown limited or neutral results for bgICH management, this single-center study using propensity matching provides unique insights into which patients with pICH are most likely to benefit from surgical intervention based on the hemorrhage’s precise spatial distribution. The study also introduces a method of volumetric imaging analysis, easily accessible via routine CT, that could be integrated into clinical workflows to triage management strategies and identify ideal surgical candidates.

“We believe our findings have potential to refine surgical selection criteria for patients with moderate-size putaminal hemorrhages,” says first author Ahmed Kashkoush, MD, a neurosurgery resident at Cleveland Clinic.

An unmet need in basal ganglia ICH

Although bgICH leads to death or dependence in over 70% of patients, the evidence base supporting its surgical management is highly limited. Earlier trials evaluating ICH evacuation often combined lobar and basal ganglia locations, potentially masking specific benefits in subpopulations.

As a result, surgical options for bgICH remain largely unexplored. American Heart Association (AHA) guidelines from 2022, drawing from criteria used in mixed-population trials, generally recommend considering stereotactic aspiration or MIS evacuation for ICH volumes between 20 and 30 mL in patients with moderate Glasgow Coma Scale scores. However, these guidelines do not propose specific surgical selection criteria for bgICH.

Advertisement

A key anatomical difference distinguishing bgICH from lobar ICH is the dense arrangement of highly eloquent structures, such as the internal capsule and thalamus, within a compact region. This means that the efficacy of MIS evacuation — relieving mass effect — might depend on the hemorrhage’s precise spatial orientation and its pressure on neighboring structures. Based on prior Cleveland Clinic data suggesting favorable outcomes for MIS evacuation of moderate-size pICHs (10 to 50 mL) without extensive regional spread, the authors hypothesized that MIS evacuation would improve functional outcomes compared with medical management in this specific group.

Design and patient cohort

The researchers retrospectively reviewed adults admitted to Cleveland Clinic between 2013 and 2024 with spontaneous, nonlesional pICH. Inclusion required hemorrhage volumes between 10 and 50 mL, measured via volumetric CT planimetry. Exclusions included underlying structural etiologies, hemorrhagic transformation of ischemic stroke, baseline modified Rankin Scale (mRS) score > 3 and comorbidities that would prohibit surgery.

To establish equipoise, the 33 surgical patients who underwent MIS evacuation using tubular retractors were 1:1 propensity score matched to 33 medically managed patients based on ICH volume and ICH score. Medical management followed AHA recommendations, including blood pressure control and anticoagulation reversal.

The primary outcome was the utility-weighted mRS (uw-mRS) score collected within one year of hospital admission. Secondary outcomes included overall mortality, dichotomized mRS scores, ICU LOS and the incremental cost-effectiveness ratio (ICER) per quality-adjusted life year (QALY).

Advertisement

Results: Benefits in survival and resource use

Despite the initial hypothesis focusing on improved functional outcomes, uw-mRS scores were statistically similar between the surgical and medical cohorts (mean of 0.44 and 0.33, respectively; P = .174). Rates of poor functional outcome (mRS of 4 to 6) were also statistically similar. The authors suggest that the study may have been underpowered to detect a statistical difference in functional outcomes.

However, the study showed substantial benefits in survival and resource utilization:

  • Mortality.The surgical arm showed significantly lower one-year mortality compared with the medically managed arm (3% vs. 24%, respectively; P = .010).
  • ICU LOS.The surgical arm had a median ICU LOS that was 3 days shorter than in the medical arm (P = .045).
  • Cost-effectiveness.MIS pICH evacuation was cost-effective: The estimated mean ICER was $68,462.55 per QALY when compared with medical management, falling below the common willingness-to-pay threshold of $100,000 per QALY.

Role of anatomical distribution in surgical selection

The authors note that a unique feature of their analysis was the use of custom stereotactic localization modeling to determine whether the hemorrhage’s spatial distribution differentially predicted outcome based on treatment strategy. This volumetric imaging analysis showed that pICH morphology did indeed influence prognosis depending on whether medical or surgical management was used, as follows:

  • In surgically managed patients, extension of the pICH anteriorly and medially into the region of the anterior limb of the internal capsule and the caudate predicted a poor functional outcome (AUC of 0.74; P = .006). “This suggests that surgery in this anatomic location may not relieve mass effect or may cause operative morbidity impacting these eloquent structures,” notes Dr. Kashkoush.
  • Conversely, in medically managed patients, hemorrhage extension superiorly and posteriorly into the corona radiata and frontal lobe region predicted a poor functional outcome (AUC of 0.74; P = .045). “We hypothesize that MIS evacuation may specifically relieve mass effect on posteriorly located corticospinal fibers that course through the posterior limb of the internal capsule and corona radiata,” Dr. Kashkoush observes.

Advertisement

Conclusions and future directions

While acknowledging the limitations of this study’s retrospective nature and modest sample size, the authors contend that it strongly warrants further investigation in larger, potentially multicenter studies.

“Our study provides important evidence suggesting that MIS evacuation of moderate-size putaminal ICH offers significant survival and resource utilization advantages over medical management alone,” says senior author Mark Bain, MD, MS, a Cleveland Clinic vascular neurosurgeon. “The mortality benefit observed reinforces primary findings from prior surgical studies of mixed ICH.”

He adds that the differential anatomical findings suggest that spatial distribution analysis using stereotactic localization can eventually help identify patients who are most likely to benefit from surgery. “This methodology lends itself to integration into automated computer vision platforms,” Dr. Bain concludes, “which may ultimately offer clinicians a readily available decision-making adjunct based on CT imaging.”

Advertisement

Related Articles

person going into a Gamma Knife machine for radiotherapy
March 25, 2026/Neurosciences/Brain Tumor

Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma

Study uses molecular and clinical stratification to help guide patient selection

illustration of human brain with rumor at top right
March 23, 2026/Neurosciences/Brain Tumor

Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma

Phase 3 STELLAR trial underscores role of molecular stratification in glioma care

brain MRI taken from the back of the head
March 20, 2026/Neurosciences/Epilepsy

Unmasking the ‘Tethered’ Temporal Lobe: New MRI Metrics Improve Detection of Encephaloceles in Refractory Epilepsy

Early identification of temporal encephaloceles can improve surgical decision-making

brain scan with white lesion on right side

ARISE II Recommendations Chart a Course for Advancing Intracranial Hemorrhage Care

Academia, industry and government leaders develop consensus priorities

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

histopathology image with pink background and arrow pointing to round cell

New Insights on α-Synuclein Pathology and Clinical Phenotypes in Dementia With Lewy Bodies

The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis

MRI of the brain against black background

Advanced Neuroimaging and Clinical Perseverance Make Sense of a 68-Year-Old’s Progressive Symptoms

A case study in pairing imaging acumen with subspecialty expertise to yield answers and symptom relief

brain scan with colored dots over a dark gray region
March 3, 2026/Neurosciences/Epilepsy

Decoding the Insula: New Semiological Insights for Localizing Seizure Onset

Guidance from the largest cohort of SEEG-confirmed insular epilepsy patients reported to date

Ad